Guggenheim Capital’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q3 | – | Sell |
-493,584
| Closed | -$4.93M | – | 3062 |
|
|
2015
Q2 | $4.93M | Buy |
493,584
+94,673
| +24% | +$945K | 0.01% | 1167 |
|
|
2015
Q1 | $5.08M | Buy |
398,911
+118,107
| +42% | +$1.5M | 0.01% | 1152 |
|
|
2014
Q4 | $3.97M | Buy |
280,804
+17,838
| +7% | +$252K | 0.01% | 1245 |
|
|
2014
Q3 | $3.62M | Buy |
262,966
+22,605
| +9% | +$311K | 0.01% | 1356 |
|
|
2014
Q2 | $3.7M | Sell |
240,361
-56,456
| -19% | -$868K | 0.01% | 1354 |
|
|
2014
Q1 | $5.06M | Buy |
296,817
+79,786
| +37% | +$1.36M | 0.01% | 1113 |
|
|
2013
Q4 | $2.81M | Sell |
217,031
-67,870
| -24% | -$879K | 0.01% | 1459 |
|
|
2013
Q3 | $2.88M | Buy |
284,901
+43,888
| +18% | +$443K | 0.01% | 1353 |
|
|
2013
Q2 | $1.8M | Buy |
+241,013
| New | +$1.8M | 0.01% | 1564 |
|